S-23 – Powder, 1g

$29.99

S-23 – Powder, 1g is ultra-pure, analytical-grade selective androgen receptor modulator (SARM) with ≥98% purity, designed for in vitro/in vivo metabolic research and analytical testing. This lyophilized material functions as an investigational, oral, nonsteroidal SARM developed by GTX, Inc. with exceptional potency, binding to the androgen receptor with a Ki of 1.7 nM—more strongly than older SARMs such as andarine—and demonstrating closely resembling potency to anabolic steroids, making it invaluable for investigators studying muscle growth, lean body mass preservation, bone mineral density enhancement, male hormonal contraception (dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation), increased female libido, anabolic activity in muscle and bone tissue, athletic performance enhancement, and tissue-selective AR signaling pathways. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats with ED₅₀ of 0.43 mg/d in prostate and 0.079 mg/d in levator ani muscle, demonstrating potent anabolic effects. The compound mimics the activity of testosterone in the body and induces AR-mediated transcriptional activation. Available for fast, compliant shipping to all U.S. states and European countries via dedicated logistics hubs.

  • Third-party certified lot coding with publicly available COA (Certificate of Analysis) for absolute purity transparency

  • Formulation completely free of flow agents, excipients, and adulterants to ensure 100% pure S-23

  • Precision over-weighed by 5-10% inside vessel to compensate for natural adhesion loss during laboratory powder transfer

  • UV-resistant PET single-wall jar with tamper-proof seal engineered for transit safety and chemical stability

Category:
Description

S-23 – Powder, 1g

This premium, laboratory-grade research compound delivers ultra-pure raw S-23 powder at ≥98% purity, representing the highest standard for modern scientific investigations into potent selective androgen receptor modulation and anabolic signaling mechanisms in muscle and bone. The lyophilized crystalline powder form provides investigators with a single-compound reference standard ideal for analytical testing, in vitro cell culture modeling of AR-mediated pathways, and in vivo preclinical research applications where precise S-23 administration is critical for studying muscle growth, male contraception, and potent androgenic effects with steroid-like efficacy.

S-23 was discovered by GTX, Inc. (now part of Ionix) and represents one of the most potent SARMs developed, with potency closely resembling that of anabolic steroids while maintaining nonsteroidal structure. In preclinical studies, it demonstrated excellent anabolic-to-androgenic ratio and reversible spermatogenesis suppression.

All shipments to the 50 United States are fulfilled directly from primary U.S. production facilities, ensuring 2-5 business day delivery nationwide. International orders to the United Kingdom and continental Europe are processed through our dedicated United Kingdom shipping hub, which streamlines customs clearance and reduces transit times across all European countries. This dual-hub logistics infrastructure guarantees seamless, compliant delivery while maintaining chemical integrity throughout transit.

  • Public third-party lab reports with unique lot-coding ensure absolute transparency for every batch sold

  • Formulation contains zero flow agents, excipients, or adulterants—pure S-23 only

  • Strategic over-weighing compensates for powder adhesion loss, guaranteeing minimum 1g recoverable material

  • PET single-wall jar features UV-resistant construction and tamper-proof seal for transit safety


Technical Specifications & Chemical Profile

Chemical Property Specification Data
Product Name S-23 – Powder, 1g
Common Synonyms Mastorin, S23, GTX-23, (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide, Selective Androgen Receptor Modulator, SARM
CAS Number 1010396-29-8
Molecular Formula C₁₈H₁₃ClF₄N₂O₃
Molar Mass 416.75 g/mol
IUPAC Name (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
SMILES CC@(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F
Primary Target Mechanism Investigational oral selective androgen receptor modulator (SARM) developed by GTX, Inc. ; potent oral SARM with Ki = 1.7 nM ; binds to androgen receptor more strongly than older SARMs such as andarine ; nonsteroidal SARM closely resembling potency of anabolic steroids ; induces AR-mediated transcriptional activation in CV-1 cells ; mimics activity of testosterone in the body ; good ratio of anabolic to androgenic effects ; dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation of treatment (male hormonal contraceptive) ; increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats ; ED₅₀ in prostate = 0.43 mg/d; ED₅₀ in levator ani muscle = 0.079 mg/d ; increases muscle growth; promotes anabolic activity in muscles and bone tissue ; lean body mass preservation; bone mineral density enhancement; increased female libido ; male hormonal contraception; athletic performance enhancement; energy increase; tissue-selective AR activation; effective and reversible agent for hormonal male contraception in rats ; encountered as novel designer drug by 2020 ; banned in sport; on World Anti-Doping Agency (WADA) Prohibited List; banned by National Collegiate Athletic Association (NCAA) ; not legally allowed in dietary supplements in US; possibly unsafe; reports of liver damage, heart attack, stroke after use; liver disease contraindication; pregnancy and breast-feeding contraindication; possibly unsafe for most people when taken by mouth
Physical Form White to off-white crystalline powder (lyophilized)
Relative Density 1.48 g/cm³ (Predicted)
Solubility DMSO: 250 mg/mL (599.88 mM, sonication recommended) ; 10% DMSO + 90% Saline: <10 mg/mL (suspension); 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline: 10 mg/mL (suspension); dissolve by heating/sonication if necessary; polyglycols: soluble
Storage Powder: -20°C (-4°F) for 3 years; In solvent: -80°C for 1 year ; minimize open air exposure; store in cool, dry place; protect from light and moisture
In Vivo Formulation 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline: 10 mg/mL (24 mM, suspension); add solvents sequentially; clarify solution before adding next; working solution prepared and used immediately

Research Applications & Storage Protocols

Potent SARM-Mediated AR Agonism & Muscle/Male Contraception Profiling

S-23 (also known as Mastorin) functions as an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc. as a potential male hormonal contraceptive. The compound is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM, demonstrating exceptional potency for androgen receptor binding. S-23 binds to the AR (Ki = 1.7 nM) and induces AR-mediated transcriptional activation in CV-1 cells, confirming its mechanism as an AR agonist. It binds to the androgen receptor more strongly than older drugs such as andarine with a Ki of 1.7 nM, demonstrating superior potency compared to earlier-generation SARMs. S23 SARM is a nonsteroidal selective androgen receptor modulator (SARM) known for its potency, closely resembling that of anabolic steroids, providing steroid-like effects without steroidal structure. S-23 is a type of chemical known as a selective androgen receptor modulator (SARM) that mimics the activity of testosterone in the body, providing comprehensive androgenic effects. In animal studies, S-23 showed both a good ratio of anabolic to androgenic effects, and dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation of treatment, confirming its dual therapeutic potential for muscle growth and male contraception. Administration of S-23 to castrated animals increases the weights of the androgen-dependent organ dose-dependently with the ED₅₀s of S-23 in the prostate and levator ani muscle of 0.43 and 0.079 mg/d, respectively, demonstrating potent tissue-specific anabolic effects. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats, confirming broad androgenic tissue activation. The compound has been shown to increase female libido, promote anabolic activity in muscles and bone tissue, and act as a male contraceptive, demonstrating comprehensive therapeutic applications. S-23 is an effective and reversible agent for hormonal male contraception in rats, confirming its potential as a male contraceptive. S-23 is used to increase energy, improve athletic performance, increase muscle growth, and for other uses, demonstrating broad research applications. This potent SARM mechanism positions S-23 as a critical tool compound for investigating muscle growth research, lean body mass preservation studies, bone mineral density enhancement pathways, male hormonal contraception models, increased female libido studies, anabolic activity in muscle and bone tissue, athletic performance enhancement, and potent androgen receptor signaling in preclinical models, offering potential therapeutic insights with steroid-like potency but nonsteroidal structure. S-23 is banned by the World Anti-Doping Agency (WADA) and the National Collegiate Athletic Association (NCAA), and there have been reports of liver damage, heart attack, and stroke after use, confirming significant safety concerns for human use.

Handling & Storage Guidelines

  • Long-Term Storage: Store powder at -20°C (-4°F) for up to 3 years for optimal stability; in solvent at -80°C for 1 year. Minimize open air exposure; store in cool, dry place; protect from light and moisture; PET single-wall jar provides UV resistance; shelf life 36 months at -20°C

  • Solubility: DMSO: 250 mg/mL (599.88 mM, sonication recommended); Polyglycols: soluble; 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline: 10 mg/mL (24 mM, suspension); dissolve by heating/sonication if necessary; add solvents sequentially; clarify solution before adding next; working solution prepared and used immediately; aqueous solutions have limited solubility

  • Appearance: White to off-white powder; clear solutions in DMSO and polyglycols when properly dissolved; relative density 1.48 g/cm³ (predicted)

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.

Additional information
pa_feature

Discountinued

pa_form

Powders

pa_types

SARMs

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “S-23 – Powder, 1g”